North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of:
- NICE 30 day TA for daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma – consultation closes 5pm on Monday 19th October
- NENC Formulary Working Group actions – September 2026 – consultation closes 5pm on Monday 2nd November
- NENC wound management formulary – consultation closes 5pm on Monday 2nd November
Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.
All active consultations can be accessed at https://ntag.nhs.uk/consultations/.